Tally clinical trial -cognitive impairment

https://www.tallyschizophreniatrial.com/EN-US/am-i-eligible.html?utm_source=source12&utm_medium=influencer&utm_campaign=cureclick&AD=WP16&CID=cucl12&GmsXqg

About the investigational drug

The TALLY clinical trial aims to understand if an investigational drug could be safe and potentially effective in impacting CIAS.

This potential treatment is a positive allosteric modulator (potentiator) of the AMPA receptor that represents a mechanistically novel approach to the treatment of CIAS.

https://www.tallyschizophreniatrial.com/EN-US/TallyClinicalTrial.html#about-the-investigation-drug

In an early study involving a small number of patients, it showed a potential to impact cognitive function in patients with CIAS.

This topic was automatically closed 90 days after the last reply. New replies are no longer allowed.